Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016630
Filing Date
2019-05-07
Accepted
2019-05-07 17:22:12
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-10q_20190331.htm 10-Q 1698484
2 EX-31.1 drrx-ex311_11.htm EX-31.1 15731
3 EX-31.2 drrx-ex312_10.htm EX-31.2 15587
4 EX-32.1 drrx-ex321_7.htm EX-32.1 6078
5 EX-32.2 drrx-ex322_6.htm EX-32.2 6226
6 GRAPHIC grfhxo5mi0uw000004.jpg GRAPHIC 15608
7 GRAPHIC grfhxo5mi0uw000003.jpg GRAPHIC 18161
8 GRAPHIC grfhxo5mi0uw000005.jpg GRAPHIC 32345
9 GRAPHIC grfhxo5mi0uw000002.jpg GRAPHIC 21219
10 GRAPHIC grfhxo5mi0uw000001.jpg GRAPHIC 31240
  Complete submission text file 0001564590-19-016630.txt   6313945

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT drrx-20190331.xml EX-101.INS 1381534
12 XBRL TAXONOMY EXTENSION SCHEMA drrx-20190331.xsd EX-101.SCH 42686
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drrx-20190331_cal.xml EX-101.CAL 52834
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20190331_def.xml EX-101.DEF 151024
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20190331_lab.xml EX-101.LAB 313863
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20190331_pre.xml EX-101.PRE 266341
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 19804234
SIC: 2834 Pharmaceutical Preparations